Medtronic (MDT)
Health Care · Medical devices and diagnostics
Global medical device leader deploying pacemakers, defibrillators, spinal implants, surgical robotics, and diabetes management systems to alleviate pain, restore health, and extend life across 150+ countries.
What Medtronic does
Medtronic plc is a global healthcare technology company headquartered in Ireland that develops, manufactures, and distributes device-based medical therapies and services. The company operates three primary reportable segments: Cardiovascular Portfolio (cardiac rhythm management, structural heart, coronary and vascular products), Neuroscience Portfolio (neurological and spinal therapies), and Medical Surgical Portfolio (surgical instruments, respiratory solutions, and other medical devices). Medtronic serves healthcare systems, physicians, clinicians, and patients in over 150 countries, with a recent spin-off of its Diabetes Business (MiniMed Group IPO in March 2026) now conducted separately.
Themes: ["Cardiac devices and heart failure management","Implantable medical devices","Minimally invasive cardiology","Remote patient monitoring","Neuroscience and spinal care","Digital health and data analytics","MRI-compatible implantable devices","Leadless pacing technology"]
Fundamentals
- Price$82.39 as of 2026-07-09 close
- Market cap$104.8B as of 2026-07-10
- 1-year return-7.4% as of 2026-07-09 close
- P/E21.81 as of 2026-07-10
- Net margin+13.2% as of 2026-07-10
- Gross margin+65.3% as of 2026-07-10
- ROE+9.8% as of 2026-07-10
- Debt / equity0.57 as of 2026-07-10
- Revenue growth (YoY)+8.4% as of 2026-07-10
- Revenue CAGR (3y)+5.2% SEC XBRL
- Beta0.58 as of 2026-07-10
Dividend: yield +3.5%; 5-year non-decreasing per-share dividend streak (SEC XBRL).
Key risks (from latest filing)
["Separation of Diabetes Business: In March 2026, Medtronic spun off MiniMed as an independent public company, creating operational, financial, and strategic risks from the loss of this business segment and ongoing integration challenges.","Regulatory and compliance complexity: Operating in 150+ countries subjects Medtronic to varying medical device regulations and potential regulatory changes that could impact product approvals, manufacturing standards, and market access.","Product liability and litigation: The filing discloses significant litigation charges and product liability exposure inherent to medical device manufacturing, which could result in material financial and reputational impacts."]
Competitors & peers
- Abbott Laboratories (ABT)
- Boston Scientific (BSX)
- Philips Healthcare
- GE HealthCare
- Siemens Healthineers
- Johnson & Johnson (JNJ)
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.